Western Oncolytics

Western Oncolytics takes the most cutting-edge cancer treatments that show promise in laboratory research and proves their efficacy to patients in clinical trials. Their lead therapy, WO-12, delivers therapeutic genes that train the immune system to fight a wide range of cancers with limited side effects and in combination with other treatments.

Funding: Angels, Tiberius II

Stage: Preclinical

News: Western Oncolytics Closes $2.5 Million Series A to Advance Cancer Immunotherapy